Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9530]
News [23409]
Articles [1991]
Editorials [134]
Conferences [465]
elearning [298]
2013 ecancer highlights
Prof Gordon McVie - ecancer and European Institute of Oncology
2013 ecancer highlights ( Prof Gordon McVie - ecancer and European Institute of Oncology )
11 Dec 2013
2013 ecancermedicalscience article highlights
Prof Gordon McVie - ecancer and European Institute of Oncology
2013 ecancermedicalscience article highlights ( Prof Gordon McVie - ecancer and European Institute of Oncology )
11 Dec 2013
Initial phase III results of the first trial in newly diagnosed multiple myeloma
Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France
Initial phase III results of the first trial in newly diagnosed multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France )
10 Dec 2013
Adjuvant therapy in early stage ER-positive, HER2 - invasive breast cancer
Dr Hope Rugo - UCSF Carol Franc Buck Breast Care Center, San Francisco, USA
Adjuvant therapy in early stage ER-positive, HER2 - invasive breast cancer ( Dr Hope Rugo - UCSF Carol Franc Buck Breast Care Center, San Francisco, USA )
10 Dec 2013
The place of the Oncotype DX Breast Cancer Assay – and the treatment approach
Dr Hope Rugo - UCSF Carol Franc Buck Breast Care Center, San Francisco, USA
The place of the Oncotype DX Breast Cancer Assay – and the treatment approach ( Dr Hope Rugo - UCSF Carol Franc Buck Breast Care Center, San Francisco, USA )
10 Dec 2013
How Recurrence Score result influences treatment decisions
Dr Hope Rugo - UCSF Carol Franc Buck Breast Care Center, San Francisco, USA
How Recurrence Score result influences treatment decisions ( Dr Hope Rugo - UCSF Carol Franc Buck Breast Care Center, San Francisco, USA )
10 Dec 2013
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and...
Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3 ( Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA )
8 Dec 2013
Treating ALL patients with T cells targeted for CD19
Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA
Treating ALL patients with T cells targeted for CD19 ( Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA )
8 Dec 2013
Chimeric antigen receptor produces complete responses and long-term persistence...
Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL ( Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in...
Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
T cells engineered with chimeric antigen receptor targeting CD19 produce...
Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence ( Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
Removal of alpha/beta T cells and of CD19 B cells in children With acute...
Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy
Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia ( Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy )
8 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation